Extract
Noninvasive, clinically applicable measurements of biomarkers for diagnosis of asthma in early life are needed. We hypothesised that profiles of volatile organic compounds (VOCs) in exhaled breath samples may serve such a purpose.
Abstract
Exhaled volatile organic compound measurements do not aid the clinician diagnosing asthma in children http://ow.ly/Z2d930lpZ60
Footnotes
Conflict of interest: M.G. Fuglsbjerg has nothing to disclose.
Conflict of interest: M.A. Rasmussen has nothing to disclose.
Conflict of interest: K.S. Hansen has nothing to disclose.
Conflict of interest: A. Smolinska has nothing to disclose.
Conflict of interest: J.W. Dallinga has nothing to disclose.
Conflict of interest: F-J. van Schooten is indicated as the inventor on a pending patent for a method for the diagnosis of airway disease inflammatory subtypes by the Université de Liège, Centre Hospitalier Universitaire de Liège and Universiteit Maastricht.
Conflict of interest: J. Stokholm has nothing to disclose.
Conflict of interest: K. Bønnelykke has nothing to disclose.
Conflict of interest: H. Bisgaard reports receiving grants from the Lundbeck Foundation and the Ministry of Health, Denmark, during the conduct of the study; consultancy fees from Boehringer Ingelheim and Chiesi Pharmaceuticals; and grants from Novo Nordisk foundation, outside the submitted work.
Conflict of interest: B.L. Chawes has nothing to disclose.
- Received February 12, 2018.
- Accepted August 1, 2018.
- Copyright ©ERS 2018
This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.